| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Newamsterdam Pharma Company N.V. (NAMSW) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 662.8K | $17.23M | - | |
| CEO | 477.8K | $12.42M | - | |
| Other | 73.1K | $1.90M | - | |
| Dir | 10.8K | $281.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Lange Louis G | Director | Sell | 44,619 | $30.42 | $1,357,229.51 | -67.8% | - | - | |
| Feb 26, 2026 | Davidson Michael H.66 | Chief Executive Officer | Sale+OE | 306,293 | $34.53 | $10,575,091.20 | -9.4% | - | - | |
| Jan 28, 2026 | Kooij Louise Frederika | Chief Accounting Officer | Sale+OE | 72,428 | $32.25 | $2,335,859.52 | -59.8% | -17.3% | - | |
| Jan 21, 2026 | Somaiya Mayur Ian | Chief Financial Officer | Sale+OE | 100,000 | $32.61 | $3,260,617.98 | -20.2% | - | - |